1.15
Precedente Chiudi:
$1.12
Aprire:
$1.13
Volume 24 ore:
783.73K
Relative Volume:
4.92
Capitalizzazione di mercato:
$46.39M
Reddito:
$63.15M
Utile/perdita netta:
$-40.30M
Rapporto P/E:
-0.6886
EPS:
-1.67
Flusso di cassa netto:
$-44.47M
1 W Prestazione:
-1.71%
1M Prestazione:
-20.14%
6M Prestazione:
-17.27%
1 anno Prestazione:
-62.05%
Tela Bio Inc Stock (TELA) Company Profile
Nome
Tela Bio Inc
Settore
Industria
Telefono
484-320-2930
Indirizzo
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Confronta TELA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
TELA
Tela Bio Inc
|
1.15 | 49.87M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
128.90 | 223.51B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
101.58 | 149.67B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
371.18 | 142.37B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
105.33 | 134.64B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.67 | 50.34B | 5.88B | 1.34B | 799.60M | 2.3489 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Iniziato | Lake Street | Buy |
| 2019-12-03 | Iniziato | Canaccord Genuity | Buy |
| 2019-12-03 | Iniziato | JMP Securities | Mkt Outperform |
| 2019-12-03 | Iniziato | Jefferies | Buy |
| 2019-12-03 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Tela Bio Inc Borsa (TELA) Ultime notizie
What analysts say about TELA Bio Inc stockBullish Engulfing Patterns & Explosive Profit Trading - earlytimes.in
Will TELA Bio Inc. stock continue dividend increasesWeekly Stock Summary & Reliable Breakout Forecasts - moha.gov.vn
TELA Bio, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
TELA Bio Set to Spotlight Soft-Tissue Innovations at Major Healthcare Conference - MyChesCo
TELA Bio Unveils New Wave of Hiring With Stock Grants Tied to Growth Push - MyChesCo
TELA Bio Inc Stock Analysis and ForecastPrice Gap Trading Strategies & Free Explosive Return Secrets - earlytimes.in
TELA Bio Posts Steady Growth as Strategic Shift Sparks New Commercial Momentum - MSN
Goodwin Advises TELA Bio On $13 Million Underwritten Registered Direct Offering And Credit Refinancing - Mondaq
How to track smart money flows in TELA Bio Inc.2025 AllTime Highs & Consistent Return Strategy Ideas - newser.com
What MACD signals say about TELA Bio Inc.July 2025 Setups & Weekly High Return Forecasts - newser.com
Measuring TELA Bio Inc.’s beta against major indicesPortfolio Value Summary & High Accuracy Trade Signal Alerts - newser.com
How hedge fund analytics apply to TELA Bio Inc. stockBuy Signal & Expert Approved Trade Ideas - newser.com
How buybacks impact TELA Bio Inc. stock valuePortfolio Update Summary & Stepwise Swing Trade Plans - newser.com
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
TELA Bio (NASDAQ:TELA) Given New $4.00 Price Target at Canaccord Genuity Group - Defense World
Why TELA Bio Inc. stock is a value investor pickIPO Watch & Weekly Top Stock Performers List - newser.com
What dividend safety score for TELA Bio Inc. stockJuly 2025 Setups & Expert-Curated Trade Recommendations - newser.com
Canaccord Genuity Maintains TELA Bio (TELA) Buy Recommendation - MSN
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - MarketScreener
Canaccord Genuity Lowers Price Target on TELA Bio (TELA) to $4.0 - GuruFocus
Major Investment Alert: EW Healthcare Partners Fund 2 Acquires Millions in TELA Bio Stock - TipRanks
Owner EW Healthcare Partners Fund 2 LP Buys 3,604,000 ($4M) Of Tela Bio Inc [TELA] - TradingView
[Form 4] TELA Bio, Inc. Insider Trading Activity - Stock Titan
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio (NASDAQ: TELA) grants 30,200 RSUs and 25,000 stock options as inducement awards - Stock Titan
Does TELA Bio Inc. show high probability of rebound2025 Support & Resistance & Free Safe Capital Growth Stock Tips - newser.com
TELA Bio Appoints William Plovanic to Board - MSN
TELA Bio Reports Revenue Growth and Strategic Moves - MSN
TELA Bio’s Earnings Call: Growth Amid Challenges - TipRanks
Can TELA Bio Inc. stock deliver surprise earnings beatOil Prices & Target Return Focused Stock Picks - newser.com
TELA Bio, Inc. (NASDAQ:TELA) Q3 2025 Earnings Call Transcript - Insider Monkey
TELA Bio Set to Unveil Innovations at Piper Sandler’s Premier Healthcare Conference! - MSN
Citizens Maintains TELA Bio (TELA) Market Outperform Recommendation - Nasdaq
TELA Bio Secures $70M Loan for Growth Initiatives - TipRanks
TELA Bio Welcomes Jim Hagen with Strategic Equity Grant - MSN
Piper Sandler lowers TELA Bio stock price target to $1.25 on soft Q3 results By Investing.com - Investing.com South Africa
Piper Sandler lowers TELA Bio stock price target to $1.25 on soft Q3 results - Investing.com Nigeria
TELA Bio, Inc. Enter into Credit Agreement and Guaranty with Perceptive Credit Holdings V, LP - MarketScreener
[8-K] TELA Bio, Inc. Reports Material Event | TELA SEC FilingForm 8-K - Stock Titan
Analyst Matt O'Brien Reiterates Neutral Rating for TELA Bio (TEL - GuruFocus
Citizens Maintains TELA Bio (TELA) Rating, Lowers Price Target | - GuruFocus
These Analysts Cut Their Forecasts On TELA Bio After Q3 Earnings - Benzinga
TELA Bio stock price target lowered to $5 at Citizens on lower ASP - Investing.com Nigeria
Tela Bio Inc Azioni (TELA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):